vimarsana.com

Page 4 - Safer Technologies Program Ste News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Brightline launches autism care program for caregivers and more digital health briefs

Also: Pear Therapeutics receives FDA SteP designation for its product candidate focused on acute and chronic pain, and Carbon Health launches its diabetes management program.

Yuri maricichDavid grodbergMyoung chaBreakthrough devices programCarbon healthSteady healthSafer technologies program steEarly startSafer technologies programMedical devicesBreakthrough devices

FDA grants STeP designation for Pear Therapeutics neurobehavioral digital therapeutic

Pear Therapeutics (Nasdaq:PEAR) announced today that it received STeP designation from the FDA for its Pear-010 product candidate.

Yuri maricichMarie thibaultSafer technologies program stePear therapeuticsTechnologies program

Lover App Is The First Sex Therapy App To Be Granted Approval From The U S Food And Drugs Administration (FDA)

SAN FRANCISCO, Calif. (PRWEB) February 03, 2022 (February 3, 2022) Lover, the digital therapeutic app for improving users’ sex lives and treating sexual

Jas bagniewskiBritney blairLerer hippeauNick pendleLover executive teamDrug administrationSafer technologies program steLover executiveManta rayGlobal founders capitalPrivacy policySafer technologies programPress release

Startup looks to help folks curb sexual dysfunction with an app

Californian startup Lover recently landed $2 million for their module-based sexual health offering.

United statesJas bagniewskiLerer hippeauSafer technologies program steHealthy pleasure groupCleveland clinicManta rayGlobal founders capitalTechnologies program

MCRA Expands Neurology Division into Medical Robotics, Exoskeletal and Brain Computer Interface Market

/PRNewswire/ MCRA, LLC, a leading medical device, in-vitro diagnostic, and biologics advisory firm and clinical research organization (CRO) integrating U.S..

New yorkUnited statesAlyssa howardDevjani sahaTim marjeninNeurology regulatory affairsNeurological regulatory affairsOffice of neurologyBreakthrough devices programViscogliosi brothersInternational regulatoryClinical research organizationClinical researchEarly feasibility programSafer technologies program steOffice of clinical evidence

vimarsana © 2020. All Rights Reserved.